Optimizing the Biodistribution & Pharmacokinetics of Abdera’s ROVEr Platform to Maximize Tumor Uptake
- Designing a modular platform for optimizing pharmacokinetics to maximize tumor uptake while minimizing off-target exposure
- Expanding the options available to engineer new functionality into antibody-based targeted radiotherapies
- Enabling protein and linker engineering that tunes BioD and clearance for new targets